These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study. Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036 [TBL] [Abstract][Full Text] [Related]
24. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment. Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112 [TBL] [Abstract][Full Text] [Related]
25. Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis? Kalatha T; Arnaoutoglou M; Koukoulidis T; Hatzifilippou E; Bouras E; Baloyannis S; Koutsouraki E J Int Med Res; 2019 May; 47(5):2187-2198. PubMed ID: 30982375 [TBL] [Abstract][Full Text] [Related]
26. Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study. Azzimonti M; Preziosa P; Pagani E; Valsasina P; Tedone N; Vizzino C; Rocca MA; Filippi M J Neurol; 2023 Sep; 270(9):4296-4308. PubMed ID: 37202603 [TBL] [Abstract][Full Text] [Related]
27. Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up. Lee AJ; Stark JH; Hayes SM; J Alzheimers Dis; 2024; 100(1):357-374. PubMed ID: 38875035 [TBL] [Abstract][Full Text] [Related]
28. Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex. Tedone N; Preziosa P; Meani A; Pagani E; Vizzino C; Filippi M; Rocca MA Mol Psychiatry; 2023 Apr; 28(4):1783-1792. PubMed ID: 36806391 [TBL] [Abstract][Full Text] [Related]
35. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006 [TBL] [Abstract][Full Text] [Related]
36. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718 [TBL] [Abstract][Full Text] [Related]
37. Correlation between White Matter Hyperintensities Related Gray Matter Volume and Cognition in Cerebral Small Vessel Disease. Wang Y; Yang Y; Wang T; Nie S; Yin H; Liu J J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105275. PubMed ID: 32992182 [TBL] [Abstract][Full Text] [Related]
38. Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis. Fleischer V; Ciolac D; Gonzalez-Escamilla G; Grothe M; Strauss S; Molina Galindo LS; Radetz A; Salmen A; Lukas C; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kümpfel T; Zettl UK; Knop M; Tumani H; Wiendl H; Gold R; Bittner S; Zipp F; Groppa S; Muthuraman M; Ann Neurol; 2022 Feb; 91(2):192-202. PubMed ID: 34967456 [TBL] [Abstract][Full Text] [Related]
40. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis. Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]